TY  - CONF

T1  - COST-EFFECTIVENESS ANALYSIS OF CASPOFUNGIN VERSUS AMPHOTERICIN B, VORICONAZOLE, AND ANIDULAFUNGIN IN THE TREATMENT OF INVASIVE CANDIDIASIS

JO  - VALUE HEALTH

PY  - 2008/11/01

AU  - Verheggen BG

AU  - Heeg BMS

AU  - Vos CBJ

AU  - Van Hout BA

ED  - 

VL  - 11

IS  - 6

SP  - A437

EP  - A437

Y2  - 2024/12/22

ER  -